Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban versus standard anticoagulation for pediatric venous thromboembolism
NL-OMON47183Phase 3Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in venous thromboembolism (VTE) comparing Edoxaban with Standard of care anticoagulation (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2018; status: active, not recruiting.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON47183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47183.